:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Eli Ben‐Michael, Lindsay Page, Luke Keele
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Statistics in Medicine
Online Access:	https://onlinelibrary.wiley.com/doi/10.1002/sim.10054
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
by: Jonathan C. Moyer, et al.
Published: (2024)

Balancing versus modelling in weighted analysis of non‐randomised studies with survival outcomes: A simulation study
by: Tim Filla, et al.
Published: (2024)

Estimating generalized propensity scores with survey and attrition weighted data
by: Daniel F. McCaffrey, et al.
Published: (2024)

Bioequivalence Design With Sampling Distribution Segments
by: Luke Hagar, et al.
Published: (2025)

A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
by: Samuel K Sarkodie, et al.
Published: (2024)

Bayesian Adaptive Enrichment Design for Continuous Biomarkers
by: Yue Tu, et al.
Published: (2025)

A comparison of hyperparameter tuning procedures for clinical prediction models: A simulation study
by: Zoë S. Dunias, et al.
Published: (2024)

Penalized weighted smoothed quantile regression for high‐dimensional longitudinal data
by: Yanan Song, et al.
Published: (2024)

Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
by: Shuxi Zeng, et al.
Published: (2024)

Review of weighted exponential random graph models frameworks applied to neuroimaging
by: Yefeng Fan, et al.
Published: (2024)

Robust best linear weighted estimator with missing covariates in survival analysis
by: Ching‐Yun Wang, et al.
Published: (2024)

A sparse factor model for clustering high‐dimensional longitudinal data
by: Zihang Lu, et al.
Published: (2024)

Targeted learning in observational studies with multi‐valued treatments: An evaluation of antipsychotic drug treatment safety
by: Jason Poulos, et al.
Published: (2024)

Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes
by: Dustin J. Rabideau, et al.
Published: (2024)

Group sequential designs for clinical trials when the maximum sample size is uncertain
by: Amin Yarahmadi, et al.
Published: (2024)

A sequential, multiple assignment, randomized trial design with a tailoring function
by: Holly Hartman, et al.
Published: (2024)

Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers
by: Yanping Chen, et al.
Published: (2024)

Assurance methods for designing a clinical trial with a delayed treatment effect
by: James A. Salsbury, et al.
Published: (2024)

A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
by: Stephen Schüürhuis, et al.
Published: (2024)

Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
by: Yunfei Wang
Published: (2024)

Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
by: Wenhao Cao, et al.
Published: (2024)

A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
by: Tianyu Zhan
Published: (2024)

Approximate maximum likelihood estimation in cure models using aggregated data, with application to HPV vaccine completion
by: John D. Rice, et al.
Published: (2024)

Letter to the editor: The use of fast approximate random forests using subsampling (rfsrc.fast) does not support the conclusion on sample sizes needed for random survival forests
by: Elena Albu, et al.
Published: (2024)

Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
by: Luana Boumendil, et al.
Published: (2024)

A latent variable approach to jointly modeling longitudinal and cumulative event data using a weighted two‐stage method
by: Madeline R. Abbott, et al.
Published: (2024)

Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
by: Jialu Fang, et al.
Published: (2024)

Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
by: Peiran Liu, et al.
Published: (2024)

A multi‐arm multi‐stage platform design that allows preplanned addition of arms while still controlling the family‐wise error
by: Peter Greenstreet, et al.
Published: (2024)

Utilizing local likelihood in regression discontinuity design: Investigating the impact of antiretroviral therapy eligibility on retention in clinical HIV care in South Africa
by: Jaehyun Seo, et al.
Published: (2024)

Interconnections of Multimorbidity‐Related Clinical Outcomes: Analysis of Health Administrative Claims Data With a Dynamic Network Approach
by: Hao Mei, et al.
Published: (2025)

Tuning LASSO Models for Propensity Score Weighting and Using Synthetic Negative Control Exposures for Residual Bias Detection
by: Richard Wyss, et al.
Published: (2026)

Robust inference methods for meta‐analysis involving influential outlying studies
by: Hisashi Noma, et al.
Published: (2024)

The Harms of Class Imbalance Corrections for Machine Learning Based Prediction Models: A Simulation Study
by: Alex Carriero, et al.
Published: (2025)

Collaborative inference for treatment effect with distributed data‐sharing management in multicenter studies
by: Mengtong Hu, et al.
Published: (2024)

A simulation study of the performance of statistical models for count outcomes with excessive zeros
by: Zhengyang Zhou, et al.
Published: (2024)

The spike‐and‐slab quantile LASSO for robust variable selection in cancer genomics studies
by: Yuwen Liu, et al.
Published: (2024)

Time‐varying dynamic Bayesian network learning for an fMRI study of emotion processing
by: Lizhe Sun, et al.
Published: (2024)

Instability of the AUROC of Clinical Prediction Models
by: Florian D. van Leeuwen, et al.
Published: (2025)

Model‐based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging?
by: Morgane Philipp, et al.
Published: (2024)